Loading...
XSHG
603233
Market cap2.87bUSD
Dec 05, Last price  
17.83CNY
1D
-0.50%
1Q
3.84%
IPO
22.74%
Name

DaShenLin Pharmaceutical Group Co Ltd

Chart & Performance

D1W1MN
XSHG:603233 chart
P/E
22.20
P/S
0.77
EPS
0.80
Div Yield, %
1.74%
Shrs. gr., 5y
-3.14%
Rev. gr., 5y
18.92%
Revenues
26.50b
+8.01%
3,252,460,2263,706,656,0744,545,011,0075,265,481,8596,273,722,0227,421,196,9038,859,273,70811,141,165,08214,582,865,28216,759,335,26421,248,086,69224,531,390,15226,496,547,000
Net income
915m
-21.58%
149,183,213197,382,181265,501,554395,434,058430,188,669474,960,964531,633,897702,661,9611,062,181,101791,230,9801,035,723,8341,166,498,182914,754,950
CFO
3.11b
-2.13%
289,310,273288,219,956448,578,297468,587,221495,601,186640,388,127873,639,8441,707,770,7071,953,915,8281,554,994,8633,756,573,4353,173,848,3323,106,300,978
Dividend
Jun 21, 20240.31 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

DaShenLin Pharmaceutical Group Co., Ltd. manufactures, wholesales, and retails pharmaceutical products in China. The company was founded in 1999 and is based in Guangzhou, China.
URL
http://www.dslyy.com/
IPO date
Jul 31, 2017
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT